- Pfizer Expands Cost-Cutting Measures, Reaffirms Outlook WSJ
- Pfizer Earnings Beat Isn’t Enough to Ease Stock Worries Barron’s
- Pfizer leans on cost cuts to offset falling revenue Reuters
- Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall CNBC
- Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales with COVID infections in retreat MarketWatch